Preservation of Venous Valvular Function After PMT for Acute DVT
Enrolling by invitation · Not applicable
Conditions studied: Acute Deep Venous Thrombosis of Femoral Vein (Disorder)
In brief
To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.
Key facts
- Study ID
- NCT05588284
- Run by
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- People needed
- 100
- Starts
- 2022-06-06
- Expected to finish
- 2026-12-30
- Last updated by the study team
- 2026-05-05
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with acute symptomatic proximal DVT involving the femoral, and/or popliteal vein, common femoral vein, iliac veins (with or without other involved ipsilateral veins) were enrolled at seven vascular centers in China. Patients were treated with PCDT via Zelante device (Boston Scientific).
You may not qualify if…
- Participants were excluded if they had symptoms for more than 14 days.
Where it is running
- Chuzhou People's Hospital — Chuzhou, Anhui, China
- Center hospital of Putu — Shanghai, Shanghai Municipality, China
- Central Hospital of Songjiang — Shanghai, Shanghai Municipality, China
- North Branch of Shanghai Ninth People's Hospital — Shanghai, Shanghai Municipality, China
- Shanghai Ninth People's Hospital — Shanghai, Shanghai Municipality, China
- Fengchen Hospital — Shanghai, Shanghai Municipality, China
- Taizhou Municipal hospital — Taizhou, Zhejiang, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.